plendil 10 mg retard filmtabletta
astrazeneca kft. - felodipine -
naloxon-human 0,4 mg/ml oldatos injekció
teva gyógyszergyár zrt. - a naloxon -
felodipin-astrazeneca 2,5 mg retard filmtabletta
astrazeneca kft. - felodipine -
irinotecan accord 20 mg/ml koncentrátum oldatos infúzióhoz
accord healthcare polska sp. z o.o. - irinotekán-hidroklorid -
felodipin-astrazeneca 5 mg retard filmtabletta
astrazeneca kft. - felodipine -
ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - szelektív immunszuppresszánsok - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
di-adreson f aquosum 25 mg injekció
n.v. organon - prednizolon; ösztradiol -
rivotril 1 mg/ml koncentrátum és oldószer oldatos injekcióhoz
cheplapharm arzneimittel gmbh - clonazepam -
paraplatin 50 mg oldatos injekció
bristol-myers squibb kft. - karboplatin -
novantrone 10 mg/5 ml injekció
meda pharma hungary kft. - mitoxantrone -